©2018

LUMAYAS

Investment,
Trading, & Financial Insights

November 12, 2018

Last week, Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics released their third quarter financial results.

All three of the biotech companies are currently developing treatments using CRISPR-Cas9 gene editing technology. They are also all still pre...

November 6, 2018

One area of the biotech industry I find particularly interesting is genetic engineering.

For the past few months, I've been closely following the race between three similar publicly traded companies, all of which are competing to get the first genome editing t...

Please reload

Recent Posts

Please reload

Archive

Please reload

Tags

Please reload